A randomized, double blind, parallel, safety and efficacy study of to investigate the effect of Sugammadex on bleeding profile of living donor liver transplantation .

Trial Profile

A randomized, double blind, parallel, safety and efficacy study of to investigate the effect of Sugammadex on bleeding profile of living donor liver transplantation .

Recruiting
Phase of Trial: Phase IV

Latest Information Update: 09 Feb 2017

At a glance

  • Drugs Sugammadex (Primary) ; Atropine; Neostigmine
  • Indications Neuromuscular blockade; Postoperative haemorrhage
  • Focus Therapeutic Use
  • Most Recent Events

    • 05 Feb 2017 Status changed from not yet recruiting to recruiting.
    • 24 Oct 2016 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top